Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer
Más información
Título según WOS: | Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer |
Título según SCOPUS: | Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer |
Título de la Revista: | Breast Cancer Research |
Volumen: | 13 |
Número: | 2 |
Editorial: | Springer Nature |
Fecha de publicación: | 2011 |
Idioma: | English |
URL: | http://breast-cancer-research.com/content/13/2/R21 |
DOI: |
10.1186/bcr2833 |
Notas: | ISI, SCOPUS |